Innovations in Inhaled Nitric Oxide Delivery
In this edition of our "Industry Analysis" series, RT magazine speaks with manufacturers of inhaled nitric oxide delivery systems about the latest market innovations in the iNO industry.
Category: Pulmonary Hypertension
Pulmonary Hypertension
Latest
Innovations in Inhaled Nitric Oxide Delivery
In this edition of our “Industry Analysis” series, RT magazine speaks with manufacturers of inhaled nitric oxide delivery systems about the latest market innovations in the iNO industry.
Read More
Pulmonary Artery Denervation Had Clinical Benefits in Pulmonary Hypertension
Pulmonary artery denervation (PADN) could reduce mean right atrial pressure, mean pulmonary artery pressure, and pulmonary vascular resistance in pulmonary hypertension patients.
Read More
Mallinckrodt Expands Rollout of INOmax Evolve DS
Mallinckrodt has begun a national rollout of the INOmax Evolve DS delivery system, which is FDA-cleared to provide inhaled nitric oxide to certain neonatal ICU patients in order to improve oxygenation and reduce the need for extracorporeal membrane oxygenation.
Read More
FDA Grants Orphan Drug Status to Pulmonary Arterial Hypertension Treatment
ZMA001, in development for pulmonary arterial hypertension, has been designated as an Orphan Drug by the US Food and Drug Administration.
Read More
Hormone Replacement Therapy May Improve Pulmonary Hypertension
Use of hormone replacement therapy (HRT) in women was associated with lower mean pulmonary artery pressure and higher right ventricular fractional shortening and right ventricular ejection fraction, according to research presented at ATS 2024.
Read More
FDA Approves Merck’s Injection for Pulmonary Arterial Hypertension
The injection on top of background therapy significantly improved exercise capacity and multiple secondary outcome measures compared to background therapy alone.
Read More
Aria CV Implants First Patient with Pulmonary Hypertension System
Aria CV Inc reports its first patient was implanted with the Gen 2 Aria CV Pulmonary Hypertension System.
Read More
Cell-based Therapy Safe for Pulmonary Arterial Hypertension
Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, according to a study led by Cedars-Sinai investigators.
Read More
Guidance for Diagnosis and Treatment of Pulmonary Hypertension Related to ILD
The Pulmonary Fibrosis Foundation and Pulmonary Hypertension Association have developed a position statement that addresses gaps in the diagnosis and treatment of patients living with pulmonary hypertension related to interstitial lung disease.
Read More
Pulmonary Rehabilitation Gets ‘Strong’ Recommendation in New ATS Guideline
The latest guideline from the American Thoracic Society reaffirms benefits for patients with COPD as well as pulmonary hypertension and interstitial lung disease.
Read More
Janssen Submits New Drug Application for Investigational Single-Tablet Combo Therapy to Treat PAH
The Janssen Pharmaceutical Companies of Johnson & Johnson is seeking FDA approval of an investigational single-tablet combination therapy of macitentan and tadalafil for the long-term treatment of pulmonary arterial hypertension.
Read More
Complications for Balloon Technique for CTEPH Patients Decrease Significantly
A Michigan Medicine-led study reveals that the once-feared severe complications that occur during balloon pulmonary angioplasty have dropped in recent years.
Read More
Market Analysis: The Impact of Cylinder-free Systems on Inhaled Nitric Oxide Delivery
RT magazine spoke with manufacturers of inhaled nitric oxide delivery systems about the latest market innovations in the iNO industry, specifically about the impact of cylinder-free (“tankless”) systems, plus research on its potential use to treat other cardiopulmonary diseases.
Read More
Combo Pill for Pulmonary Hypertension Outperforms Monotherapy
The outcomes for patients with pulmonary arterial hypertension taking macitentan and tadalafil together in a single pill have been detailed in a new study, which shows significant improvement compared to those taking either drug alone.
Read More
Inhaled Nitric Oxide Delivery: Past, Present, and Future
Inhaled nitric oxide has been utilized as a pulmonary vasodilator for over 20 years and research is ongoing to uncover the usefulness of iNO in several lung diseases and disorders.
Read More
Pulmonary Hypertension Guidelines Call for Earlier Diagnosis
Earlier detection of pulmonary hypertension in the community and expedited referral of high-risk or complex patients are recommended in the new ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Read More
Novel Blood Test Evaluates Pulmonary Arterial Hypertension Severity
NIH researchers have found that a novel blood test can be used to easily evaluate disease severity in patients with pulmonary arterial hypertension (PAH) and predict survivability.
Read More
Gene on Y Chromosome Protects Against Pulmonary Hypertension
A gene on the Y chromosome protects against pulmonary hypertension, which may partially explain why the disease occurs four times more often in women than men.
Read More
Treating Chronic Hypertension in Early Pregnancy Benefits Parents, Infants
Adults treated with medication for chronic hypertension present before or during the first 20 weeks of pregnancy had fewer adverse pregnancy outcomes compared to adults who did not receive antihypertensive treatment.
Read More
Study: Evaluating Risk Stratification in Pulmonary Arterial Hypertension
The findings of an evaluation of several risk assessment tools for pulmonary arterial hypertension were recently published in the journal Respiration.
Read More
Sleep Apnea in Pregnancy Tied to Hypertension, Metabolic Syndrome
The presence of sleep apnea measured both during pregnancy and two to seven years after delivery was associated with the development of hypertension and metabolic syndrome.
Read More
COPD Phenotyping Can Help Manage Pulmonary Hypertension
Patients with pulmonary hypertension and chronic obstructive pulmonary disease can now be identified by looking at three clinical variables, new research shows.
Read More
Sleep Apnea Common in Pulmonary Hypertension
A recent study highlights the importance of treating pulmonary hypertension in patients with obstructive sleep apnea.
Read More
Higher Blood Pressure Levels During COVID-19 Pandemic
The COVID-19 pandemic is associated with higher blood pressure levels among middle-aged adults across the US, according to research published in the journal Circulation.
Read More